A

Director Director DIN 08526412
DIN 08526412 First appointment Aug 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2019
Shareholding value •••• Premium profile

About Ankush

Data last updated:

Ankush was a Director at Sbs Biotech Corporate Private Limited (2019–2021) and Director at Utile Therapeutics Private Limited (2019–2021). The companies operate in Pharma.

DIN 08526412
Primary Designation Director
Industry Pharma
First Appointment 01 Aug 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Sep 20192019₹14.08 Cr (FY 2024)Active
Utile Therapeutics Private Limited U24299HR2019PTC081768
Director01 Aug 20192019₹4.61 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sbs Biotech Corporate Private Limited
Utile Therapeutics Private Limited
Premium access

Shareholding and investment profile for Ankush

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankush

Ankush was first appointed on 01 Aug 2019 as Director at Utile Therapeutics Private Limited.

Ankush held 2 earlier board appointments: Sbs Biotech Corporate Private Limited (Director, 10 Sep 2019 to 19 Feb 2021); Utile Therapeutics Private Limited (Director, 01 Aug 2019 to 19 Feb 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available